Japan encourages the development of reimbursable medical devices through R&D grants, tax incentives, and expedited regulatory pathways for innovative technologies. Programs like the Sakigake Designation and consultation support from MHLW and PMDA assist manufacturers. Premium pricing for cutting-edge devices under the NHI system further incentivizes innovation while addressing healthcare needs.
